Mean pupillary diameter—at the time the surgeon performs capsulorhexis (mm) · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraoperative surgical time—total intraoperative time (min) · patients undergoing cataract surgery
1 finding from 1 review
AE: participant‐reported ocular discomfort—week 1 · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
AE: participant‐reported ocular discomfort—month 1 · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean pupillary diameter—at the time the surgeon performs capsulorhexis (mm) · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraoperative surgical time—total intraoperative time (min) · patients undergoing cataract surgery
1 finding from 1 review
AE: participant‐reported ocular discomfort—week 1 · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
AE: participant‐reported ocular discomfort—month 1 · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients undergoing cataract surgery
1 finding from 1 review
Intraoperative surgical time—total intraoperative time (min) · patients undergoing cataract surgery
1 finding from 1 review
Total time it took for the surgeon to perform phacoemulsification (seconds) · patients undergoing cataract surgery
1 finding from 1 review
AE: participant‐reported ocular discomfort—week 1 · patients undergoing cataract surgery
It is very uncertain whether topical mydriatics changes AE: participant‐reported ocular discomfort—week 1 compared with intracameral mydriatics (very low certainty).
1 finding from 1 review
AE: participant‐reported ocular discomfort—month 1 · patients undergoing cataract surgery
Topical mydriatics probably leads to higher AE: participant‐reported ocular discomfort—month 1 compared with intracameral mydriatics (moderate certainty).
1 finding from 1 review
Need for analgesic prescription for pain (supplemental analgesic requirements) · breast cancer surgery
Paravertebral anaesthesia with or without sedation may leads to lower postoperative analgesic requirement compared with general anaesthesia (low certainty).
1 finding from 1 review
Number of patients with postoperative nausea and vomiting (postoperative care unit) · breast cancer surgery
Paravertebral anaesthesia with or without sedation probably leads to lower postoperative nausea and vomiting (PONV) compared with general anaesthesia (moderate certainty).
1 finding from 1 review
Postoperative pain at 2 hours · breast cancer surgery
1 finding from 1 review
Postoperative pain at 24 hours on rest · breast cancer surgery
1 finding from 1 review
Postoperative pain at 6 hours on movement · breast cancer surgery
1 finding from 1 review
Pain (VAS scores) on movement at postoperative day 1 Scale from: 0 to 10. · breast cancer surgery
1 finding from 1 review
All‐cause mortality · breast cancer surgery
1 finding from 1 review